FOXO TECHNOLOGIES INC. Legal Fees
FOXO TECHNOLOGIES INC. (FOXO) reported Legal Fees of $73.24 thousand for the 12-month period ending 2025-12-31, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. legal fees for the quarter ending 2025-12-31 was $72.74K.
- FOXO TECHNOLOGIES INC. legal fees for the quarter ending 2025-09-30 was $0.00.
- FOXO TECHNOLOGIES INC. legal fees for the quarter ending 2025-06-30 was $0.00.
- FOXO TECHNOLOGIES INC. legal fees for the quarter ending 2025-03-31 was $500.00.
- FOXO TECHNOLOGIES INC. legal fees for fiscal 2024 was $500.00.
| Period end | Legal Fees | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $72.74K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-14 | $72.74K derived: sum of 2 quarters · filed 2026-08-14 | $72.74K derived: sum of 3 quarters · filed 2026-08-14 | $73.24K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $500.00 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | $500.00 10-Q · filed 2025-08-19 | |||
| 2025-03-31 | $500.00 10-Q/A · filed 2025-08-19 | ||||
| 2025-03-15 | $2.50K 10-K · filed 2026-04-15 | ||||
| 2025-03-07 | $500.00 10-K · filed 2026-04-15 | ||||
| 2024-12-31 | $500.00 10-K · filed 2025-04-15 | ||||
| 2023-09-19 | $643.00K 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |